Spotlight
Topic
Brand Insights
Subscribe
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
UN Competition Policy Meeting to Discuss Big Pharma 'Tactics'
October 14, 2016
Potentially anticompetitive practices in the pharmaceutical industry are among topics to be discussed at a global meeting on competition next week in Geneva, Switzerland. Referring to agreements which occur when a patent holder compensates a competitor to delay or abandon the launch of a generic drug, United Nations Conference on Trade and Development (UNCTAD) economist Ebru Gokce commented: "We're not questioning the merit of patent protection. We're questioning the anti-competitive nature of practices, such as pay-for-delay agreements, that prolong market exclusivity." The 15th Intergovernmental Group of Experts Meeting on Competition Law and Policy takes place from October 19 to 21.
Recent Videos
Related Content
